FGF21 and metabolic dysfunction-associated steatotic liver disease: In diet-induced obese mice suffering from NAFLD, Xu et al. [158] described that administering FGF21 reduced body weight and whole-body fat mass, blood glucose, insulin and lipid levels, and reversed hepatic steatosis.